Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience.
Shaughnessy PJ, Ornstein D, Ririe D, Callander N, Anderson JE, Pollack MS, Freytes CO, Cruz J, Rodriquez T, Bachier C, LeMaistre CF. Shaughnessy PJ, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2002;8(8):420-8. doi: 10.1053/bbmt.2002.v8.pm12234167. Biol Blood Marrow Transplant. 2002. PMID: 12234167 Free article. Clinical Trial.
What is quality in a transplant program?
LeMaistre CF, Loberiza FR Jr. LeMaistre CF, et al. Biol Blood Marrow Transplant. 2005 Apr;11(4):241-6. doi: 10.1016/j.bbmt.2004.12.329. Biol Blood Marrow Transplant. 2005. PMID: 15812388 Free article.
Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.
Shaughnessy PJ, Bachier C, Grimley M, Freytes CO, Callander NS, Essell JH, Flomenberg N, Selby G, Lemaistre CF. Shaughnessy PJ, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2005 Mar;11(3):188-93. doi: 10.1016/j.bbmt.2004.11.022. Biol Blood Marrow Transplant. 2005. PMID: 15744237 Free article. Clinical Trial.
High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells.
Bachier C, Potter J, Potter G, Sugay R, Shaughnessy P, Chan K, Jude V, Madden R, LeMaistre CF. Bachier C, et al. Among authors: lemaistre cf. Biol Blood Marrow Transplant. 2012 Jul;18(7):1055-60. doi: 10.1016/j.bbmt.2011.12.500. Epub 2011 Dec 16. Biol Blood Marrow Transplant. 2012. PMID: 22178402 Free article.
Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma.
Shaughnessy P, Alexander W, Tran H, Ririe D, Splichal J, Pollack M, Bachier C, LeMaistre C. Shaughnessy P, et al. Mil Med. 2006 Feb;171(2):161-5. doi: 10.7205/milmed.171.2.161. Mil Med. 2006. PMID: 16578989 Clinical Trial.
123 results